Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Eczema Matters

Browsing Articles Tagged with the Topic ofbiologics

Two new atopic dermatitis biologics show promising results in phase IIb clinical trials

Two new atopic dermatitis biologics show promising results in phase IIb clinical trials

Galderma’s nemolizumab and Dermira’s lebrikizumab are two new biologics for atopic dermatitis that are working their...

Should I go on dupilumab if I’m thinking about getting pregnant?

Should I go on dupilumab if I’m thinking about getting pregnant?

There are lots of unknowns when it comes to biologics and pregnancy. That's why it's important to ask questions — and ...

Colorado researchers urge raising the bar for treating severe eczema

Colorado researchers urge raising the bar for treating severe eczema

The researchers suggest doctors combine basic skincare techniques with cutting-edge treatments to maximize the well-bein...

It’s time for our annual treatment roundup

It’s time for our annual treatment roundup

In the “Golden Age of Eczema,” people with atopic dermatitis have more treatment options than ever before, with even...

Biologics may show greater risk for infection than systemics

Biologics may show greater risk for infection than systemics

Off-label use of biologic treatments for atopic dermatitis may double the risk for serious infection compared to systemi...

‘Regular Joe Schmo’ makes miraculous eczema recovery

‘Regular Joe Schmo’ makes miraculous eczema recovery

Steve Gawron of Long Island, New York, is getting used to his clear skin after battling severe atopic dermatitis for alm...

Dupixent may soon be approved for teenagers

Dupixent may soon be approved for teenagers

Dupixent, a biologic drug for moderate to severe AD, may soon be available to patients aged 12 to 18 if the treatment co...

A Second Biologic Drug for Atopic Dermatitis Makes Its Way to Market

A Second Biologic Drug for Atopic Dermatitis Makes Its Way to Market

Following on the heels of Dupixent (dupilumab)—the first-ever biologic drug for atopic dermatitis (the most common typ...

NEA Celebrates Another Win for Access to New Atopic Dermatitis Therapy Dupixent

NEA Celebrates Another Win for Access to New Atopic Dermatitis Therapy Dupixent

ICER, a nonprofit that conducts independent reviews on clinical effectiveness and value of treatments, found Dupixent t...

Q & A: Introducing Biologics with Dr. Paul Yamauchi

Q & A: Introducing Biologics with Dr. Paul Yamauchi

In March, the FDA approved Dupixent, the first biologic medication for adults with moderate to severe atopic dermatitis....

First Biologic Approved for Moderate to Severe Atopic Dermatitis

First Biologic Approved for Moderate to Severe Atopic Dermatitis

The U.S. Food and Drug Administration approved Dupixent (dupilumab), the first biologic medication for adults with moder...

Understanding Biologic Drugs

Understanding Biologic Drugs

Biologic medications are already being used to treat diseases including rheumatoid arthritis, psoriasis and Crohn’s di...